HyperSight(TM)-CBCT based monitoring of sarcopenia during definitive radiotherapy of prostate cancer: a longitudinal feasibility study.
- DOI
- 10.1186/s13014-026-02856-3
- Published
- 2026 May 29
- Container
- Radiation oncology (London, England)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s13014-026-02856-3,
title = {HyperSight(TM)-CBCT based monitoring of sarcopenia during definitive radiotherapy of prostate cancer: a longitudinal feasibility study.},
author = {Siefert V and V Bettenhausen J and Bicu AS and Schmidt R and Willam M and Eckl M and Stieler F and Ehmann M and Buergy D and Fleckenstein J and Beuthien-Baumann B and Schlemmer HP and Froelich MF and Schoenberg SO and Giordano FA and Boda-Heggemann J and Dreher C},
year = {2026},
journal = {Radiation oncology (London, England)},
doi = {10.1186/s13014-026-02856-3},
url = {https://doi.org/10.1186/s13014-026-02856-3}
}RIS
TY - JOUR TI - HyperSight(TM)-CBCT based monitoring of sarcopenia during definitive radiotherapy of prostate cancer: a longitudinal feasibility study. AU - Siefert V AU - V Bettenhausen J AU - Bicu AS AU - Schmidt R AU - Willam M AU - Eckl M AU - Stieler F AU - Ehmann M AU - Buergy D AU - Fleckenstein J AU - Beuthien-Baumann B AU - Schlemmer HP AU - Froelich MF AU - Schoenberg SO AU - Giordano FA AU - Boda-Heggemann J AU - Dreher C PY - 2026 JO - Radiation oncology (London, England) DO - 10.1186/s13014-026-02856-3 UR - https://doi.org/10.1186/s13014-026-02856-3 ER -
APA
V, S., J, V. B., AS, B., R, S., M, W., M, E., F, S., M, E., D, B., J, F., B, B., HP, S., MF, F., SO, S., FA, G., J, B., & C, D. (2026). HyperSight(TM)-CBCT based monitoring of sarcopenia during definitive radiotherapy of prostate cancer: a longitudinal feasibility study.. Radiation oncology (London, England). https://doi.org/10.1186/s13014-026-02856-3
Source records
- pubmed · retrieved 2026-09-25T20:09:43.630Z